Zynex Shares Fall After Tricare Suspends Payments

Dow Jones03-11
 

By Sabela Ojea

 

Shares of Zynex fell after the it said that the health insurance company Tricare--which accounts for as much as 25% of its total revenue--has temporarily suspended payments as it reviews prior claims.

The medical device maker's stock was down 19% to $5.70 in post-market trading on Tuesday. Through the close the company's shares have dropped 44% in the past 12 months.

In response to Tricare's decision, Zynex said it would cut 15% of its workforce. The job cuts are expected to primarily affect corporate employees and drive savings of around $35 million annually, the company said.

Zynex said that it plans to meet with Tricare in April and believes it has good evidence to get payments reinstated.

 

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

 

(END) Dow Jones Newswires

March 11, 2025 17:41 ET (21:41 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment